Viewing Study NCT07047066


Ignite Creation Date: 2025-12-24 @ 4:22 PM
Ignite Modification Date: 2026-02-23 @ 11:34 AM
Study NCT ID: NCT07047066
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-02
First Post: 2025-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
Sponsor: Tongji Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module